Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > lice treatment market
Get a free sample of Lice Treatment Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Lice Treatment Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The lice treatment industry is characterized by the presence of several key players offering innovative solutions. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.
Prominent players operating in the lice treatment industry include:
Alliance Pharma PLC, Azurity Pharmaceuticals, Inc., Fleming Medical Ltd., Oystershell Consumer Health, Parapro Pharmaceuticals, Perrigo Company plc, Prestige Consumer Healthcare Inc., Reckitt Benckiser Group plc, Sanofi S.A., and Thornton & Ross Ltd.
North America lice treatment industry accumulated USD 461.5 million in revenue in 2023 and is expected to expand at 6.4% CAGR from 2024 to 2032, due to the presence of a larger infestation pool and the increasing children population in the region.
The OTC products segment in the market accounted for 62.6% share in 2023 and is projected to witness substantial growth from 2024 to 2032, on account of the rising environmental concerns along with consumer demand for non-toxic, eco-friendly products.
Lice treatment industry size recorded USD 1 billion in 2023 and is expected to register 6.5% CAGR from 2024 to 2032, due to the rising prevalence of lice infestations.